Zhonghong Pulin Medical Products Valuation

Q: What is the Fair Price of 300981 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300981 (CN¥14.26) is trading above our estimate of [[fair value]] (CN¥1.33)

Is 300981 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300981 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300981 (CN¥14.26) is trading above our estimate of fair value (CN¥1.33)

Significantly Below Fair Value: 300981 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300981?

Key metric: As 300981 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 300981. This is calculated by dividing 300981's market cap by their current revenue.
What is 300981's PS Ratio?
PS Ratio	2.3x
Sales	CN¥2.36b
Market Cap	CN¥5.54b

300981 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.6x
Enterprise Value/EBITDA	51.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 300981's PS Ratio compare to its peers?

The above table shows the PS ratio for 300981 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	8.5x
688151 Hubei Huaqiang High-Tech	10.5x	n/a	CN¥5.8b
688606 Hangzhou Alltest Biotech	6.6x	n/a	CN¥5.4b
002382 Blue Sail MedicalLtd	0.9x	n/a	CN¥5.6b
300942 Shenzhen Bioeasy Biotechnology	16x	n/a	CN¥4.3b
300981 Zhonghong Pulin Medical Products	2.3x	10.2%	CN¥5.5b

Price-To-Sales vs Peers: 300981 is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (8.8x).

Price to Sales Ratio vs Industry

How does 300981's PS Ratio compare vs other companies in the CN Medical Equipment Industry?

1 Company	Price / Sales	Estimated Growth	Market Cap
300358 Truking Technology	0.8x	10.9%	US$648.78m

No more companies available in this PS range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 300981 is good value based on its Price-To-Sales Ratio (2.3x) compared to the CN Medical Equipment industry average (6.4x).

Price to Sales Ratio vs Fair Ratio

What is 300981's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300981 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.3x
Fair PS Ratio	0.6x

Price-To-Sales vs Fair Ratio: 300981 is expensive based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.76

-5.2%

24.5%

iRay Technology

CN¥16.0b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥116.11

6.7%

-24.2%

Truking Technology

CN¥4.7b

Engages in medical equipment business in China and internationally.

300358

CN¥8.07

6.0%

-29.9%